- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/13 - Amines, e.g. amantadine
Patent holdings for IPC class A61K 31/13
Total number of patents in this class: 1473
10-year publication summary
101
|
113
|
124
|
120
|
123
|
111
|
93
|
98
|
86
|
40
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
27 |
Adamas Pharma, LLC | 49 |
27 |
MERZ PHARMA GmbH & CO. KGaA | 624 |
23 |
The General Hospital Corporation | 4517 |
21 |
Suven Life Sciences Limited | 129 |
19 |
Adamas Pharmaceuticals, Inc. | 27 |
16 |
Anavex Life Sciences Corp. | 61 |
13 |
Corium, LLC | 41 |
10 |
Indiana University Research and Technology Corporation | 808 |
9 |
Targacept, Inc. | 63 |
9 |
University of Florida Research Foundation, Inc. | 3883 |
8 |
Helsinn Birex Pharmaceuticals Ltd | 15 |
8 |
Recurium IP Holdings, LLC | 138 |
8 |
Allergan, Inc. | 2600 |
7 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
7 |
The Trustees of Columbia University in the City of New York | 3440 |
7 |
Aldeyra Therapeutics, Inc. | 100 |
7 |
Case Western Reserve University | 1727 |
7 |
Pharnext | 106 |
7 |
Eisai R&D Management Co., Ltd. | 1304 |
7 |
Other owners | 1226 |